Delivery Order SPE2DB20D1100-SPE2DB23FD6F7
Award Date 9/14/23
Potential Completion Date 9/15/23
Potential Value $1.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,112.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The order is to provide the medication to support DLA's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in September 2023. No set aside designation or subcontractors were indicated. This order was issued under an existing DLA medical supply vehicle to fulfill requirements...
- The Defense Logistics Agency awarded a $695.45 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 24-25, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the Department of Defense's global supply chain and distribution network, suggesting this small order for...
- The Defense Logistics Agency awarded a $1,466.49 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The order is to supply the pharmaceutical product to a Defense Logistics Agency location in Conshohocken, Pennsylvania by September 25, 2023. Amerisourcebergen will perform as the prime contractor, with the Defense Logistics Agency as the funding agency. The delivery order was issued under an existing DLA pharmaceutical supply vehicle and does not...
- The Defense Logistics Agency awarded a $436 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania for delivery by September 26, 2023 in support of the Defense Department's medical supply needs. Amerisourcebergen will provide the migraine treatment pens as the prime contractor under an unspecified multiple award contract vehicle with DLA. No set aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,990.63 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the...
- The Defense Logistics Agency awarded a delivery order valued at $556.36 to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 9, 2023 under a firm fixed price contract. No additional details were provided regarding subcontractors or the Defense Logistics Agency's programs that would provide helpful context for this small delivery order.
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Emgality 120 mg/ml pen injectors, with a ceiling value of $1,527.12. This is a firm fixed price delivery order with an ultimate completion date of September 30, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $139,090 to Amerisourcebergen Drug Corporation for the provision of 120 mg/ml Emgality pens. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 25, 2023 under the terms of the award. The Defense Logistics Agency is the funding agency for this delivery order placed against an existing Amerisourcebergen contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Emgality 120 mg/mL pen injectors, valued at $1,556.10. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a non-competitive set-aside award. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a $1,391 delivery order to Amerisourcebergen Drug Corporation for 120mg/ml Emgality pens. As the prime contractor, Amerisourcebergen will supply the biologic migraine treatment medication to the Department of Defense from its facility in Conshohocken, Pennsylvania under a firm fixed price contract. No subcontractors or set aside designations were identified. The delivery order was issued on September 8, 2023 under an existing DLA pharmaceuticals contract...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FD6F7Delivery Order
The Defense Logistics Agency awarded a $1,112.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 mg/ml Emgality pens. The prime contractor will deliver the medication to a location in Conshohocken, Pennsylvania by September 15, 2023 in support of the Defense Logistics Agency's medical supply procurement programs. No subcontractors or set aside designations were indicated. The delivery order was awarded under an existing DLA pharmaceutical supply vehicle to fulfill the agency's short-term need for the migraine treatment drug.
Generated 12/23/23, 2:04 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/14/23 |